Repare Therapeutics Inc. (RPTX) [Rocket]

In millions, except per share items	Jun-30-23	Jun-05-23	Mar-31-23	Mar-05-23	Sep-30-22	Jun-30-22	Jun-05-22	Mar-31-22
	10-Q	8-K	10-Q	8-K	10-Q	10-Q	8-K	10-Q
Revenues	0.0	72.8	0.0	-26.2	0.0	0.0	40.1	0.0
Revenue growth		81.5%		0.4%
Cost of goods sold	0.0	42.5	0.0	0.0	0.0	0.0	39.4	0.0
Gross profit	0.0	30.2	0.0	-26.2	0.0	0.0	0.7	0.0
Gross margin		41.6%		100.0%			1.7%
Selling, general and administrative [+]	42.5	8.7	40.4	8.5	39.1	39.4	7.9	35.2
General and administrative		8.7		8.5			7.9
Other selling, general and administrative
Research and development
Other operating expenses	-37.1	33.8	-12.4		-116.8	-2.0	31.5	-0.6
EBITDA [+]
Depreciation and amortization
EBIT [+]	-5.4	-12.3	-28.0	-34.7	77.6	-37.4	-38.7	-34.6
EBIT growth	-85.5%	-68.4%	-19.2%	-0.4%	-346.3%	39.5%		60.8%
EBIT margin		-16.8%		132.6%			-96.6%
Interest income	3.5		3.4		2.0	0.5		0.1
Interest income	3.5		3.4		2.0	0.5		0.1
Other income (expense), net [+]	-6.9	3.4	-6.8	3.4	-4.1	-1.2	0.7	-0.2
Other		0.0		0.0			0.0
Pre-tax income	-8.8	-8.8	-31.3	-31.3	75.5	-38.1	-38.1	-34.7
Income taxes	3.1	3.1	3.6	3.6	0.1	0.0	0.0	0.0
Tax rate					0.1%
Net income	-11.9	-11.9	-34.9	-34.9	75.5	-38.1	-38.1	-34.8
Net margin		-16.4%		133.6%			-95.0%

Basic EPS [+]	($0.28)	($0.28)	($0.83)	($0.83)	$1.80	($0.91)	($0.91)	($0.83)
Growth	-68.8%	-68.8%	0.1%	0.1%	-316.2%
Diluted EPS [+]	($0.28)	($0.28)	($0.83)	($0.83)	$1.71	($0.91)	($0.91)	($0.83)
Growth	-68.8%	-68.8%	0.1%	0.1%	-305.3%

Shares outstanding (basic) [+]	42.1	42.1	42.0	42.0	41.9	41.9	41.9	41.9
Growth	0.5%	0.5%	0.4%	0.4%	13.0%	13.1%		13.4%
Shares outstanding (diluted) [+]	42.1	42.1	42.0	42.0	44.2	41.9	41.9	41.9
Growth	0.5%	0.5%	0.4%	0.4%	19.0%	13.1%		13.4%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.